Prostate cancer castration-resistant prostate cancer
Clinical trials for Prostate cancer castration-resistant prostate cancer explained in plain language.
Never miss a new study
Get alerted when new Prostate cancer castration-resistant prostate cancer trials appear
Sign up with your email to follow new studies for Prostate cancer castration-resistant prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (prostate, breast, colorectal, lung, or pancreatic cancer) that have not responded to standard treatments. The drug is an antibody-drug conjugate, designed to deliver a cancer-killing agent directly …
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Phase 1/2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase trial tests a new cell therapy called anti-PSMA CAR NK cells in 10 people with metastatic castration-resistant prostate cancer (mCRPC), a form of prostate cancer that no longer responds to hormone therapy. The treatment uses immune cells engineered to target a pr…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for men with advanced prostate cancer that no longer responds to standard hormone therapy. The treatment uses specially engineered immune cells (CAR-NK cells) designed to find and attack cancer cells. The main goal is to check if the t…
Matched conditions: PROSTATE CANCER CASTRATION-RESISTANT PROSTATE CANCER
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC